Clinical trial
Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer
NCT02031328
Study timeline
Study start (actual)2014-01-01Date precision: month
Registry last updated2020-11-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Adenocarcinomaunresolved
Interventions
Stereotactic Ablative RadiationRADIATION
Sponsors & collaborators
Sunnybrook Health Sciences Centrelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02031328 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.